LOW-LEVELS OF SOMATOSTATIN IN HUMAN CSF MARK DEPRESSIVE EPISODES
LOW-LEVELS OF SOMATOSTATIN IN HUMAN CSF MARK DEPRESSIVE EPISODES
复制标题
DOI:
10.1016/0306-4530(84)90003-9
复制
发表时间:
1984-01-01
影响因子:
3.7
通讯作者:
LUNDQVIST, G
中科院分区:
文献类型:
--
作者:
AGREN, H;LUNDQVIST, G
Somatostatin-like immunoreactivity was measured in the CSF of 85 inpatients with current or recent episodes of major depressive disorders, diagnosed according to Research Diagnostic Criteria (RDC) as assessed with the Schedule for Affective Disorders and Schizophrenia (SADS). Several biopsychiatric tests were run during the same week of investigation. Results indicate low levels of CSF somatostatin to be a state marker for episodes of depression characterized by sad appearance, feelings of tiredness, insomnia and subjective inability to acknowledge any external precipitants for the depression. CSF somatostatin was negatively related to platelet monoamine oxidase (MAO) activity; MAO activity appeared to account better for the degree of melancholic features than did somatostatin. The ratio between 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA) in CSF also correlated negatively with somatostatin. A positive relationship was noted between CSF xanthine and somatostatin. There was a highly significant curvilinear correlation between CSF somatostatin and serum TSH concentrations, but no correlations between CSF somatostatin and serum GH [growth hormone] or prolactin, or with plasma cortisol before or after dexamethasone.